leukemia
Supportive Care and Other Tools for Managing Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
In patients who received prior chronic lymphocytic leukemia/small lymphocytic lymphoma-directed therapy but require ...
MARCH 10, 2025
Blinatumomab Increases Disease-Free Survival for Children With Leukemia
Children with B-acute lymphoblastic leukemia who received blinatumomab plus standard chemotherapy were 61% less ...
JANUARY 15, 2025
FDA Approves Revuforj for Relapsed or Refractory Acute Leukemia With a KMT2A Translocation
The FDA approved revumenib (Revuforj, Syndax), a menin inhibitor, for relapsed or refractory acute leukemia with a ...
NOVEMBER 18, 2024
Key Treatment Principles and Recent Updates In the Management of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic lymphocytic leukemia is a lymphoproliferative disorder characterized by the accumulation of circulating ...
APRIL 10, 2024
In Highly Pretreated KMT2A-Rearranged Leukemia, Novel Targeted Therapy Achieves MRD Negativity
In highly pretreated histone lysine N-methyltransferase 2A (KMT2A)-rearranged acute leukemia, which is associated ...
FEBRUARY 9, 2024
Study Finds Lower Risk for Hematologic Cancer After Bariatric Surgery in Women
Bariatric surgery is associated with a reduced incidence of hematologic cancer, specifically in women, according to ...
OCTOBER 23, 2023
Telehealth AYA Cancer Program Helps Identify Needed Resources
When oncologists with the University of Wisconsin Carbone Cancer Center, in Madison, wanted to start a dedicated ...
MAY 25, 2022
BiTE Therapy Shows Promise in R/R ALL
Although only a phase 1b dose-finding study in patients with relapsed/refractory (R/R) B-cell precursor acute ...
MARCH 16, 2022
Survey Highlights Concerning Lack of Availability of ATRA for APL
Only 42% of institutions that treat acute leukemia patients and 31% of hospitals overall in the United States have ...
FEBRUARY 18, 2022
